Dr Rebecca Carlisle, MD | |
1500 Forest Glen Rd, C/o Pediatric Education, Hch, Silver Spring, MD 20910 | |
(301) 754-7232 | |
(301) 754-7154 |
Full Name | Dr Rebecca Carlisle |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 1500 Forest Glen Rd, Silver Spring, Maryland |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073616918 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D50285 (Maryland) | Primary |
Entity Name | Childrens Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912939703 PECOS PAC ID: 0244143170 Enrollment ID: O20031107000130 |
News Archive
The competition among pharmacy retailers such as Walgreen and Wal-Mart "to create more efficient business plans for pricing and selling prescription drugs has the potential to spur change across the pharmacy industry," the Wall Street Journal reports.
The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.
A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is associated with an increased risk as well.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160 (formerly NMED-160), a novel oral N-type calcium channel blocker.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rebecca Carlisle, MD 1500 Forest Glen Rd, C/o Pediatric Education, Hch, Silver Spring, MD 20910 Ph: (301) 754-7232 | Dr Rebecca Carlisle, MD 1500 Forest Glen Rd, C/o Pediatric Education, Hch, Silver Spring, MD 20910 Ph: (301) 754-7232 |
News Archive
The competition among pharmacy retailers such as Walgreen and Wal-Mart "to create more efficient business plans for pricing and selling prescription drugs has the potential to spur change across the pharmacy industry," the Wall Street Journal reports.
The recent launch of two clinical trials offer innovative study designs for patients with lung cancer. These clinical trials are the direct result of a National Cancer Institute sponsored workshop chaired by Drs. Fred R. Hirsch, Shakun Malik and Claudio Dansky- Ullman, that brought together the NCI Thoracic Malignancies Steering Committee, the US Food and Drug Administration, academicians, clinicians as well as industry and government stakeholders to discuss issues and challenges related to clinical trial design and biomarkers for lung cancer targeted-therapies.
A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is associated with an increased risk as well.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of a new formulation of Z160 (formerly NMED-160), a novel oral N-type calcium channel blocker.
› Verified 2 days ago
Dr. Erica Rupar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10301 Georgia Ave, #106, Silver Spring, MD 20902 Phone: 301-681-6000 | |
Dr. Robin Madden, M.D., PH.D, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10313 Georgia Ave, Suite 303, Silver Spring, MD 20902 Phone: 301-681-7020 Fax: 301-681-0147 | |
Dr. Najla Nouri Falaki, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2015 Mayflower Dr, Silver Spring, MD 20905 Phone: 301-384-0019 | |
Dr. Laila A. Mahmood, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15613 Holly Grove Rd, Silver Spring, MD 20905 Phone: 301-384-3579 | |
Dr. Cyd Patrice Campbell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 102 Southwood Ave, Silver Spring, MD 20901 Phone: 301-213-3679 | |
Dr. Lisa S Thompson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-905-3600 | |
Liza S Burns, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10301 Georgia Ave, Suite 106, Silver Spring, MD 20902 Phone: 301-681-6000 Fax: 301-681-3153 |